Training activity information
Details
Identify pregnancies requiring obstetrician or FMU referral according to guidelines
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
Considerations are suggestions about what may be useful for the trainee to think about while undertaking a training activity. They should not be considered as a mandatory checklist. Trainees should not be expected to demonstrate or provide evidence for each of the considerations listed.
- Current guidelines
- Impact of laboratory results on clinical practice
- Impact of laboratory results on different treatment options (Doppler, intrauterine transfusion (IUT), early delivery, etc.)
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Practice in accordance with antenatal serology standards and guidelines. |
| # 3 |
Outcome
Perform and interpret clinical and laboratory investigations to identify cases of haemolytic disease of the fetus or newborn (HDFN). |
| # 4 |
Outcome
Identify sequential testing algorithms appropriate to the samples under investigation for HDFN. |
| # 5 |
Outcome
Predict current and future pregnancies at highest risk of HDFN. |
| # 6 |
Outcome
Identify and advise healthcare professionals on appropriate actions to manage HDFN. |
| # 7 |
Outcome
Develop management plans including selection of blood components for mother, fetus and neonates during pregnancy. |